Načítá se...
Clinical Trials of Immunomodulation in Ischemic Stroke
Inflammatory mechanisms are currently considered as a prime target for stroke therapy. There is evidence from animal studies that immune signals and mediators can have both detrimental and beneficial effects in particular stages of the disease process. Moreover, several of these mechanisms are turne...
Uloženo v:
| Vydáno v: | Neurotherapeutics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5081130/ https://ncbi.nlm.nih.gov/pubmed/27412685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0458-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|